Skip to main content
. 2008 Aug;44(12):1717–1725. doi: 10.1016/j.ejca.2008.05.007

Table 2.

Comparing the distributions of histological tumour characteristics and tumour site between relapsers and non-relapsers

Non-relapsers N (%) Relapsers N (%) p-Value Relapsers excluding systemic relapsers p-Value
Site of primary
 Axial 48 (33.1) 47 (35.9) 0.6 37 (31.9) 0.8
 Limb 97 (66.9) 84 (64.1) 79 (68.1)



Ulceration
 No 112 (91.1) 85 (82.5) 0.1 74 (82.2) 0.1
 Yes 11 (8.9) 18 (17.5) 16 (17.8)



Tumour infiltrating lymphocytes
 None 6 (4.9) 5 (4.9) 0.3 5 (5.6) 0.4
 Mild 59 (48.0) 59 (57.3) 52 (57.8)
 Non-brisk 31 (25.2) 26 (25.2) 21 (23.3)
 Brisk 27 (22.0) 13 (12.6) 12 (13.3)



Regression
 No 91 (74.0) 75 (72.8) 0.8 65 (72.2) 0.8
 Yes 32 (26.0) 28 (27.2) 25 (27.8)



Initial incisional biopsy
 No 124 (85.5) 117 (90.7) 0.2 104 (90.4) 0.2
 Yes 21 (14.5) 12 (9.3) 11 (9.6)



Vertical growth phase
 No 10 (8.1) 3 (2.9) 0.1 3 (3.3) 0.1
 Yes 113 (91.9) 100 (97.1) 87 (96.7)



Mitotic ratea
 Mean (s.d.) 2.3 (3.4) 4.0 (5.9) 0.01 4.2 (6.2) 0.01



Vessel invasionb
 No 121 (98.4) 97 (94.2) 0.1 85 (94.4) 0.1
 Yes 2 (1.6) 6 (5.8) 5 (5.6)

p-Value from Pearson’s chi-squared test for independence unless otherwise stated.

The number of missing data points ranges between 2 and 52 due to lack of histological information for some patients.

a

Two-tailed t-test, mean and standard deviation reported.

b

Fisher’s exact test.